Lacidipine protects against cyclosporine-induced nephrotoxicity in rats

Nephron

Volumn 81, Issue 1, 1999, Pages 60-66

  Naidu, M U R ^a   Kumar, K Vijay ^a   Shifow, Anwar Ahmed ^a   Prayag, A ^a   Ratnakar, K S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Calcium channel blocker; Cyclosporine; Lacidipine; Nephrotoxicity

Indexed keywords

CALCIUM ANTAGONIST; CREATININE; CYCLOSPORIN; LACIDIPINE; LITHIUM ION; MALONALDEHYDE; POTASSIUM ION; SODIUM ION; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; HISTOLOGY; KIDNEY CALCIFICATION; KIDNEY TUBULE ABSORPTION; LITHIUM BLOOD LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; UREA BLOOD LEVEL; URINE VOLUME;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINE; DIHYDROPYRIDINES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; LITHIUM; MALE; RATS; RATS, WISTAR;

EID: 0032952762     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045247     Document Type: Article

References (42)

1. Keown PA, Stiller CR: Cyclosporine - allograft rejection: in Massry SG, Glassock RJ (eds): Textbook of Nephrology, ed 2. Baltimore. Williams & Wilkins, 1995, vol 2, pp 1648-1655.
2. Keown PA, Stiller C, Wallance AC: The nephrotoxicity of cyclosporine A; in Williams M, Burdick J, Salez K (eds): Kidney Transplant Rejection: Diagnosis and Treatment, ed 2. New York, Marcel Dekker, 1992, pp 637-671.
3. Wilson PD, Hartz PA: Mechanism of cyclosporine A toxicity in defined cultures of renal tubule epithelia: A role for cysteine protease. Cell Biol Int Reports 1991;15:1243-1258.
4. Rankin GO, Valentovic MA, Teets NJ, Nicoll DW, Sutherland CH, Brown PI: Effect of calcium antagonism by nifedipine and chlorpromazine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats. Toxicology 1991;66:19-37.
5. L'Azou B, Lakhdar B, Potaux L, Aparicio M, Cambar J: Influence of verapamil on cyclosporine-induced constriction in human or murine isolated glomerules. Presse Méd 1991;29: 2043-2044.
6. Nagineni CN, Migra BC, Lee DBN, Yanagawa N: Cyclosporine A calcium channel interaction. Transplant Proc 1987;19:1358-1363.
7. Rooth P, Davidson I, Diller K, Talijedab I-B: Beneficial effects of calcium antagonist pretreatment and albumin infusion on cyclosporine A-induced impairment of kidney microcirculation in mice. Transplant Proc 1987;19: 3602-3605.
8. Loutzeniser R, Epstein M, Horton C, Sonke P: Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by diltiazem. Am J Physiol 1986;250:F619-F626.
9. Kon V, Sguira M, Inagami T, Harvie BR, Ichikawa I, Hoover RL: Role of endothelin in cyclosporine induced glomerular dysfunction. Kidney Int 1990;37:1487-1491.
10. Assis SM, Monteiro JL, Seguro AC: L-Arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997;63: 1070-1073.
11. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G: Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993;43:706-711.
12. Whiting PH, Simpson JG: Lithium clearance measurements as an indicator of cyclosporin A nephrotoxicity in the rat. Clin Sci 1988;74: 173-178.
13. Bernheim FM, Bernheim ML, Wilbur KM: The reaction between TBA and the oxidation products of certain lipids. J Biol Chem 1948; 174:257-264.
14. Jackson NM, Hsu Ch, Visscher GE, Venkatachalam MA, Humes HD: Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity. J Pharmacol Exp Ther 1987;242:749-756.
15. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Benett WM: Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996;50:1110-1117.
16. Ruilope LM, Lahera V, Rodicio JL: Evaluation of the renal effects of calcium antagonists. J Cardiovasc Pharmacol 1994;23:S49-S53.
17. Romero JC, Raij L, Granger JP, Rullope LM, Rodicio JL: Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 1987;10:140-151.
18. Repelli A, Baldinelli A, Zingaretti O, Espinosa E, Salvi S, Fulgheri P: The effects of antihypertensive therapy on renal function. J Hypertens 1991;9:537-540.
19. Ruggenenti P, Perico N, Mosoni L, Gaspari F, Benigni, Amuchastegui CS, Bruzzi I, Remuzzi G: Calcium-channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993;43:706-711.
20. English J, Evan A, Hoghton DC, Bennett WM: Cyclosporine-induced acute renal dysfunction in the rat: Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987;44:135-144.
21. Wagner K, Neumayer HH: Prevention of delayed graft function by diltiazem, a calcium antagonist, in recipients of cadaveric renal transplants treated with Sandimmun: 2 randomized studies. Lancet 1985;ii:1355-1356.
22. Bilo HJG, Stoff TJ, Korstanje MJ, Cook EFI, Donker AJM: Fish oil and renal function in cyclosporine-treated psoriasis patients (abstract). Kidney Int 1989;36:509.
23. Barros EJG, Boim MA, Ajen H, Ramos OL, Schor N: Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 1987;32:19-25.
24. Murray BM, Paller MS, Ferris TF: Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985;28: 767-774.
25. Fogo A, Hellings SE, Inagami T, Kon V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 1992;42:770-774.
26. Rossi NF, Churchill PC, McDonald FD, et al: Mechanism of cyclosporine A-induced renal vasoconstriction in the rat. J Pharmacol Exp Ther 1989;250:896-901.
27. Dieperink H, Kemp E, Leyssac PP, Starlint H: Cyclosporine A: Effectiveness and toxicity in a rat model. Clin Nephrol 1986;25:2736-2741.
28. Epstein M: Calcium antagonists and renal protection. Arch Intern Med 1992;152:1573-1584.
29. L'Azou B, Lagroye I, Plande J, Lakhdar B, Cambar J: Protective effect of verapamil and dopamine against cyclosporine-induced vasoconstriction in isolated glomeruli in rats. Presse Méd 1992;21:2021-2023.
30. 2 synthesis induced by cyclosporine A. Am J Physiol 1986;251:F581-F587.
31. L'Azou B, Cambar J: Prevention of cyclosporine-induced vasoconstrictive effect in rat isolated glomeruli with pharmacological vasoconstrictive agents. Toxicol In Vitro 1993;7:417-420.
32. Andoh TF, Burdmann EA, Bennet WM: Nephrotoxicitiy of immunosuppressive drags: Experimental and clinical observations. Semin Nephrol 1997;17:34-45.
33. Rob PM, Lebeau A, Nobiling, Schmid H, Bley N, Dick K, Weigelt I, Rohwer J, Gobel Y, Sack K, Classen HG: Magnesium metabolism: Basic aspects and implications of ciclosporine toxicity in rats. Nephron 1996;72:59-66.
34. Schegel J, Meier P, Kass GE, Richter C: Inhibition of cyclosporine A of the pro-oxidant-induced but not of the sodium-induced calcium release from rat kidney mitochondria. Biochem Pharmacol 1991;42:2193-2197.
35. Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S: Decrease in kidney calbindin D 28 kDa as possible mechanism mediating cyclosporine A- and FK-506-induced calcuria and tubular mineralisation. Biochem Pharmacol 1997;53:723-731.
36. Burke TJ, Singh H, Schrier RW: Calcium handling by renal tubules during oxygen deprivation injury to the kidney prior to reoxygenation. J Cardiovasc Drugs Ther 1990;4:1319-1324.
37. Schrier RW, Burke TJ: Calcium channel-blockers in experimental and human acute renal failure. Adv Nephrol 1988;17:287-300.
38. Silberberg SD, Poder TC, Lacerda AE: Endothelin increases single-channel calcium currents in coronary arterial smooth muscle cells. FEBS Lett 1989;247:68-72.
39. Van Rentagerghem C, Vigne P, Barhanin P, Schmid-Alliana A, Frelin C, Lazdunski M: Molecular mechanism of action of vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 1988;157:977-985.
40. Edwards RM, Trizna W, Ohlstein EH: Renal microvascular effects of endothelin. Am J Physiol 1990;259:F217-F221.
41. Wolf A, Clemann N, Friehauff W, Ryffel B, Cordier A: Role of reactive oxygen formation in the cyclosporine A mediated impairment of renal functions. Transplant Proc 1994;16: 2902-2907.
42. van Amsterdam FTHM, Roveri A, Maiorino Ratti E, Ursini F: Lacidipine: A dihydropyridine calcium antagonist with antioxidant activity. Free Rad Biol Med 1992;12:183-187.